NCT03439462 2024-01-02Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal CancerAadi Bioscience, Inc.Phase 1/2 Completed60 enrolled 14 charts